Report Detail

Request for Sample of this report

Pharma & Healthcare Global Eosinophilic Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4516666
    • |
  • 27 February, 2023
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Eosinophilic Disease market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500 cells/μl crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.
This report is a detailed and comprehensive analysis for global Eosinophilic Disease market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Eosinophilic Disease market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Eosinophilic Disease market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Eosinophilic Disease
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Eosinophilic Disease market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca and GSK plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Eosinophilic Disease market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Corticosteroids
Monoclonal Antibodies
Anti-cytokine Drug
Cytotoxic Drug
Market segment by Application
Eosinophilic Esophagitis
Eosinophilic Granulomatosis with Polyangiitis
Hyper-eosinophilic Syndrome
Nasal Polyposis
Other
Major players covered
Takeda Pharmaceutical Company Limited
Ellodi Pharmaceuticals
Bristol-Myers Squibb Company
AstraZeneca
GSK plc
Regeneron Pharmaceuticals Inc
Allakos Inc
Arena Pharmaceuticals Ltd
Revolo Biotherapeutics
DBV Technologies
Cipla Inc
Sun Pharmaceutical Industries Ltd
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eosinophilic Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Eosinophilic Disease, with price, sales, revenue and global market share of Eosinophilic Disease from 2018 to 2023.
Chapter 3, the Eosinophilic Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eosinophilic Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Eosinophilic Disease market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Eosinophilic Disease.
Chapter 14 and 15, to describe Eosinophilic Disease sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Eosinophilic Disease
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Eosinophilic Disease Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Corticosteroids
    • 1.3.3 Monoclonal Antibodies
    • 1.3.4 Anti-cytokine Drug
    • 1.3.5 Cytotoxic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Eosinophilic Disease Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Eosinophilic Esophagitis
    • 1.4.3 Eosinophilic Granulomatosis with Polyangiitis
    • 1.4.4 Hyper-eosinophilic Syndrome
    • 1.4.5 Nasal Polyposis
    • 1.4.6 Other
  • 1.5 Global Eosinophilic Disease Market Size & Forecast
    • 1.5.1 Global Eosinophilic Disease Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Eosinophilic Disease Sales Quantity (2018-2029)
    • 1.5.3 Global Eosinophilic Disease Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Takeda Pharmaceutical Company Limited
    • 2.1.1 Takeda Pharmaceutical Company Limited Details
    • 2.1.2 Takeda Pharmaceutical Company Limited Major Business
    • 2.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Product and Services
    • 2.1.4 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  • 2.2 Ellodi Pharmaceuticals
    • 2.2.1 Ellodi Pharmaceuticals Details
    • 2.2.2 Ellodi Pharmaceuticals Major Business
    • 2.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Product and Services
    • 2.2.4 Ellodi Pharmaceuticals Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Ellodi Pharmaceuticals Recent Developments/Updates
  • 2.3 Bristol-Myers Squibb Company
    • 2.3.1 Bristol-Myers Squibb Company Details
    • 2.3.2 Bristol-Myers Squibb Company Major Business
    • 2.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Product and Services
    • 2.3.4 Bristol-Myers Squibb Company Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bristol-Myers Squibb Company Recent Developments/Updates
  • 2.4 AstraZeneca
    • 2.4.1 AstraZeneca Details
    • 2.4.2 AstraZeneca Major Business
    • 2.4.3 AstraZeneca Eosinophilic Disease Product and Services
    • 2.4.4 AstraZeneca Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 AstraZeneca Recent Developments/Updates
  • 2.5 GSK plc
    • 2.5.1 GSK plc Details
    • 2.5.2 GSK plc Major Business
    • 2.5.3 GSK plc Eosinophilic Disease Product and Services
    • 2.5.4 GSK plc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 GSK plc Recent Developments/Updates
  • 2.6 Regeneron Pharmaceuticals Inc
    • 2.6.1 Regeneron Pharmaceuticals Inc Details
    • 2.6.2 Regeneron Pharmaceuticals Inc Major Business
    • 2.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Product and Services
    • 2.6.4 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Regeneron Pharmaceuticals Inc Recent Developments/Updates
  • 2.7 Allakos Inc
    • 2.7.1 Allakos Inc Details
    • 2.7.2 Allakos Inc Major Business
    • 2.7.3 Allakos Inc Eosinophilic Disease Product and Services
    • 2.7.4 Allakos Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Allakos Inc Recent Developments/Updates
  • 2.8 Arena Pharmaceuticals Ltd
    • 2.8.1 Arena Pharmaceuticals Ltd Details
    • 2.8.2 Arena Pharmaceuticals Ltd Major Business
    • 2.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Product and Services
    • 2.8.4 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Arena Pharmaceuticals Ltd Recent Developments/Updates
  • 2.9 Revolo Biotherapeutics
    • 2.9.1 Revolo Biotherapeutics Details
    • 2.9.2 Revolo Biotherapeutics Major Business
    • 2.9.3 Revolo Biotherapeutics Eosinophilic Disease Product and Services
    • 2.9.4 Revolo Biotherapeutics Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Revolo Biotherapeutics Recent Developments/Updates
  • 2.10 DBV Technologies
    • 2.10.1 DBV Technologies Details
    • 2.10.2 DBV Technologies Major Business
    • 2.10.3 DBV Technologies Eosinophilic Disease Product and Services
    • 2.10.4 DBV Technologies Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 DBV Technologies Recent Developments/Updates
  • 2.11 Cipla Inc
    • 2.11.1 Cipla Inc Details
    • 2.11.2 Cipla Inc Major Business
    • 2.11.3 Cipla Inc Eosinophilic Disease Product and Services
    • 2.11.4 Cipla Inc Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cipla Inc Recent Developments/Updates
  • 2.12 Sun Pharmaceutical Industries Ltd
    • 2.12.1 Sun Pharmaceutical Industries Ltd Details
    • 2.12.2 Sun Pharmaceutical Industries Ltd Major Business
    • 2.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Product and Services
    • 2.12.4 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.13 Sanofi
    • 2.13.1 Sanofi Details
    • 2.13.2 Sanofi Major Business
    • 2.13.3 Sanofi Eosinophilic Disease Product and Services
    • 2.13.4 Sanofi Eosinophilic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Sanofi Recent Developments/Updates

3 Competitive Environment: Eosinophilic Disease by Manufacturer

  • 3.1 Global Eosinophilic Disease Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Eosinophilic Disease Revenue by Manufacturer (2018-2023)
  • 3.3 Global Eosinophilic Disease Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Eosinophilic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Eosinophilic Disease Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Eosinophilic Disease Manufacturer Market Share in 2022
  • 3.5 Eosinophilic Disease Market: Overall Company Footprint Analysis
    • 3.5.1 Eosinophilic Disease Market: Region Footprint
    • 3.5.2 Eosinophilic Disease Market: Company Product Type Footprint
    • 3.5.3 Eosinophilic Disease Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Eosinophilic Disease Market Size by Region
    • 4.1.1 Global Eosinophilic Disease Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Eosinophilic Disease Consumption Value by Region (2018-2029)
    • 4.1.3 Global Eosinophilic Disease Average Price by Region (2018-2029)
  • 4.2 North America Eosinophilic Disease Consumption Value (2018-2029)
  • 4.3 Europe Eosinophilic Disease Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Eosinophilic Disease Consumption Value (2018-2029)
  • 4.5 South America Eosinophilic Disease Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Eosinophilic Disease Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 5.2 Global Eosinophilic Disease Consumption Value by Type (2018-2029)
  • 5.3 Global Eosinophilic Disease Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 6.2 Global Eosinophilic Disease Consumption Value by Application (2018-2029)
  • 6.3 Global Eosinophilic Disease Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 7.2 North America Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 7.3 North America Eosinophilic Disease Market Size by Country
    • 7.3.1 North America Eosinophilic Disease Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Eosinophilic Disease Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 8.2 Europe Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 8.3 Europe Eosinophilic Disease Market Size by Country
    • 8.3.1 Europe Eosinophilic Disease Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Eosinophilic Disease Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Eosinophilic Disease Market Size by Region
    • 9.3.1 Asia-Pacific Eosinophilic Disease Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Eosinophilic Disease Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 10.2 South America Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 10.3 South America Eosinophilic Disease Market Size by Country
    • 10.3.1 South America Eosinophilic Disease Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Eosinophilic Disease Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Eosinophilic Disease Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Eosinophilic Disease Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Eosinophilic Disease Market Size by Country
    • 11.3.1 Middle East & Africa Eosinophilic Disease Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Eosinophilic Disease Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Eosinophilic Disease Market Drivers
  • 12.2 Eosinophilic Disease Market Restraints
  • 12.3 Eosinophilic Disease Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Eosinophilic Disease and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Eosinophilic Disease
  • 13.3 Eosinophilic Disease Production Process
  • 13.4 Eosinophilic Disease Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Eosinophilic Disease Typical Distributors
  • 14.3 Eosinophilic Disease Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Eosinophilic Disease. Industry analysis & Market Report on Eosinophilic Disease is a syndicated market report, published as Global Eosinophilic Disease Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Eosinophilic Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,225.96
    		4,838.94
    		6,451.92
    		542,984.40
    		814,476.60
    		1,085,968.80
    		290,649.60
    		435,974.40
    		581,299.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo